Point-of-Care HCV Test Receives FDA Marketing Greenlight
The FDA has authorized Cepheid’s Xpert HCV test and GeneXpert Xpress System, the first point-of-care HCV test for certified settings.
Read MorePosted by Chris Wolski | Jun 28, 2024 | POC Reagents & Test Kits |
The FDA has authorized Cepheid’s Xpert HCV test and GeneXpert Xpress System, the first point-of-care HCV test for certified settings.
Read MorePosted by Andy Lundin | Jun 24, 2024 | Sepsis |
Cytovale’s IntelliSep test helped support the sepsis management program for Our Lady of the Lake Regional Medical Center.
Read MorePosted by Andy Lundin | Jun 21, 2024 | Flu & Respiratory Infections |
Researchers developed a paper strip test using CRISPR technology that can quickly and accurately diagnose various influenza strains.
Read MorePosted by Andy Lundin | Jun 20, 2024 | Cancer |
A new study reveals that AI can detect and diagnose cancer from tissue samples with 98.2% accuracy, allowing for earlier treatment.
Read MorePosted by Andy Lundin | Jun 17, 2024 | Transfusion & Transplantation Tests |
Natera launched Prospera Heart with Donor Quantity Score, enhancing its ability to detect rejection in heart transplant patients.
Read More